Europe Defibrillator Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Implantable Cardioverter Defibrillator and External) and End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities)


No. of Pages: 198    |    Report Code: TIPRE00025064    |    Category: Life Sciences

Europe Defibrillator Market
Buy Now

The Europe defibrillator market is expected to reach

US$ 3,705.85 million by 2028 from US$ 2,692.93 million in 2021; it is estimated to grow at a CAGR of 4.7% during 2021–2028.



A defibrillator is a medical device used to deliver a dose of electric current to the heart in order to treat life-threatening cardiac dysrhythmias. This current supports restoring the heart to a regular, healthy rhythm. Defibrillators can be implantable, external, transvenous, or subcutaneous based on the type required for the treatment. Some external defibrillators, also known as automated external defibrillators (AEDs), are designed so that even untrained or laypersons will be able to use them. The growth of the Europe defibrillator market is attributed to the factors such as increasing prevalence of cardiovascular diseases (CVDs) and rising training and awareness programs on cardiopulmonary resuscitation (CPR) and automated external defibrillators (AEDs). However, product recalls are likely to affect the market negatively.

 

Europe Defibrillator Market Revenue and Forecast to 2028 (US$ Million)

Europe Defibrillator Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

Europe Defibrillator Strategic Insights

Strategic insights for the Europe Defibrillator provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-defibrillator-market-strategic-framework.webp
Get more information on this report

Europe Defibrillator Report Scope

Report Attribute Details
Market size in 2021 US$ 2,692.93 Million
Market Size by 2028 US$ 3,705.85 Million
Global CAGR (2021 - 2028) 4.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Implantable Cardioverter Defibrillator and External
By End User
  • Hospitals and Clinics
  • Prehospital Care
  • Public Access
  • Home Care Settings
  • Alternate Care Facilities
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Koninklijke Philips N.V.
  • Biotronik, INC.
  • CU Medical Systems, INC.
  • Progetti SRL
  • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  • Nihon Kohden Corporation
  • Get more information on this report

    Europe Defibrillator Regional Insights

    The geographic scope of the Europe Defibrillator refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-defibrillator-market-geography.webp
    Get more information on this report

     

    Market Insights

    Increasing Prevalence of Cardiovascular Diseases (CVDs)

    Cardiovascular diseases (CVDs) are likely to remain the most significant cause of morbidity and mortality worldwide. According to the European Cardiovascular Disease Statistics, in Europe only, they account for 1.8 million deaths every year, or 36% of all deaths in the European Union. As per recent estimates, the EU has over 60 million people living with CVDs. Moreover, deaths from CVDs exceed fatalities from cancer (1.3 million every year in Europe; 26% of all deaths). In addition, according to the British Heart Foundation Factsheet 2021, around 7.6 million people are living with heart and circulatory diseases in the UK.

    Consequently, heart attacks account for more than 100,000 hospital admissions in the UK each year, equating to 280 admissions every day or one every five minutes. With the advancement of the healthcare system and infrastructure, every 7 out of 10 people survive a heart attack in the UK compared to the 1960s where more than 7 out of 10 heart attacks in the UK were fatal. In addition, over 1.4 million people in the UK approximately 1 million males and 380,000 women have survived a heart attack. Thus, the rising incidence of cardiovascular diseases and heart attacks is expected to drive the European defibrillator market during the forecast period.

     

    Product-Based Insights

    Based on product, the Europe defibrillator market is segmented into implantable cardioverter defibrillator and external. The implantable cardioverter defibrillator is subsegmented into transvenous ICD and subcutaneous ICD. Similarly, the external defibrillator segment is subsegmented into manual, wearable, and fully automated external defibrillators. In 2021, the implantable cardioverter defibrillator segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate in the coming years.

     

    Europe Defibrillator Market, by Product – 2021 and 2028

    Europe Defibrillator Market, by Product – 2021 and 2028
    Get more information on this report

    Europe Defibrillator Strategic Insights

    Strategic insights for the Europe Defibrillator provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

    strategic-framework/europe-defibrillator-market-strategic-framework.webp
    Get more information on this report

    Europe Defibrillator Report Scope

    Report Attribute Details
    Market size in 2021 US$ 2,692.93 Million
    Market Size by 2028 US$ 3,705.85 Million
    Global CAGR (2021 - 2028) 4.7%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By Product
    • Implantable Cardioverter Defibrillator and External
    By End User
    • Hospitals and Clinics
    • Prehospital Care
    • Public Access
    • Home Care Settings
    • Alternate Care Facilities
    Regions and Countries Covered Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
    Market leaders and key company profiles
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Koninklijke Philips N.V.
  • Biotronik, INC.
  • CU Medical Systems, INC.
  • Progetti SRL
  • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  • Nihon Kohden Corporation
  • Get more information on this report

    Europe Defibrillator Regional Insights

    The geographic scope of the Europe Defibrillator refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-defibrillator-market-geography.webp
    Get more information on this report

     

    End User-Based Insights

    Based on end user, the defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities. The hospitals and clinics segment held the largest share of the market in 2021. However, prehospital care is estimated to register the highest CAGR in the market during the forecast period.

     

    Strategic Insights

    Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Companies in the Europe defibrillator market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

     

    Europe Defibrillator Market – by Product

    • Implantable Cardioverter Defibrillator
      • Transvenous ICD
      • Subcutaneous ICD
    • External
      • Manual
      • Fully Automated External Defibrillators
      • Wearable

    Europe Defibrillator Market – by End User  

    • Hospitals and Clinics
    • Prehospital Care
    • Public Access
    • Home Care Settings
    • Alternate Care Facilities

     

    Europe Defibrillator Market – by Country

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Austria
    • Switzerland
    • Sweden
    • Norway
    • Denmark
    • Netherland
    • Finland
    • Portugal
    • Romania
    • Rest of Europe

    Company Profiles

    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Zoll Medical Corporation
    • Koninklijke Philips N.V.
    • Biotronik, INC.
    • CU Medical Systems, INC.
    • Progetti SRL
    • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
    • Nihon Kohden Corporation

    The List of Companies - Europe Defibrillator Market

    The List of Companies - Europe Defibrillator Market

    1. Medtronic
    2. Abbott
    3. Boston Scientific Corporation
    4. Zoll Medical Corporation
    5. Koninklijke Philips N.V.
    6. Biotronik, INC.
    7. CU Medical Systems, INC.
    8. Progetti SRL
    9. Shenzhen Mindray Bio-Medical Electronics Co., LTD.
    10. Nihon Kohden Corporation

     

    Frequently Asked Questions
    How big is the Europe Defibrillator Market?

    The Europe Defibrillator Market is valued at US$ 2,692.93 Million in 2021, it is projected to reach US$ 3,705.85 Million by 2028.

    What is the CAGR for Europe Defibrillator Market by (2021 - 2028)?

    As per our report Europe Defibrillator Market, the market size is valued at US$ 2,692.93 Million in 2021, projecting it to reach US$ 3,705.85 Million by 2028. This translates to a CAGR of approximately 4.7% during the forecast period.

    What segments are covered in this report?

    The Europe Defibrillator Market report typically cover these key segments-

    • Product (Implantable Cardioverter Defibrillator and External)
    • End User (Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, Alternate Care Facilities)

    What is the historic period, base year, and forecast period taken for Europe Defibrillator Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Defibrillator Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Europe Defibrillator Market?

    The Europe Defibrillator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Zoll Medical Corporation
  • Koninklijke Philips N.V.
  • Biotronik, INC.
  • CU Medical Systems, INC.
  • Progetti SRL
  • Shenzhen Mindray Bio-Medical Electronics Co., LTD.
  • Nihon Kohden Corporation
  • Who should buy this report?

    The Europe Defibrillator Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Defibrillator Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now